Y-ST02-PRIT

N/A

Report date: 2025/12/05 11:43:40

Base Information

Drug NameY-ST02-PRIT
Drug Alias NameY-ST02-PRIT
ClassificationRadiation-emitting products
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsProstatic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesY-Mabs Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesY-Mabs Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsProstatic Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A